+ 2.58
+ 0.78%
+ 2.29
+ 0.66%
+ 2.93
+ 0.7%
+ 1.55
+ 0.91%

Extraction Lab Hemp Synergistics Gets $1.5M Seed Investment

January 13, 2020 11:52 am
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More
Extraction Lab Hemp Synergistics Gets $1.5M Seed Investment

Hemp Synergistics, a hemp extraction laboratory producing THC-free custom CBD formulations recently announced it received $1.5 million in seed funding to launch a high-tech laboratory.

The lab has been designed to resolve the problem of inconsistent THC levels in a range of cannabinoid-based consumer products, the company told Benzinga. The 18,700 square foot facility will deliver extractions of THC-free broad-spectrum hemp distillates and custom formulated cannabinoid blends for clients in the pharmaceutical, nutraceutical, food and cosmetic markets within a Current Good Manufacturing Practices environment.

Don’t miss out on the top cannabis stories of the day. Click here to sign up for our daily insider newsletter.

“Our top priority is creating 100% THC free formulations to ensure the health and safety of all consumers. Products have been falsely marketed as THC free, or with levels below 0.3% THC, for years, when in many cases levels far exceed those claims. That is not fair to consumers and can be detrimental to their health in some instances,” Co-Founder Russ Cersosimo told Benzinga. “Hemp Synergistics will set an industry standard for a higher quality product through our technology and expertise- with or without FDA regulations.”

Hemp Synergistics has a modular design that will allow the company to scale up production and expand to locations across the country to cut down on shipping time, with ease. The company is based just outside of Pittsburgh.

Related Articles

Cannabis Movers & Shakers: Phyto, HERBL, Treez, Fyllo, Auxly, AgraFlora, Viridis

Phyto Extractions Announces Departure Of Interim CEO Phyto Extractions Inc., formerly known as Adastra Labs Holdings Ltd., (CSE: XTRX) (FRA: D2EP), said last Friday it had parted ways with J. Scott Munro, the company’s interim CEO and director. read more

Gilgamesh Pharmaceuticals Raises $27M In Series A With Prime Movers Lab

Gilgamesh Pharmaceuticals, a biotechnology company that uses psychedelic-related drugs to treat neuropsychiatric disorders, reported Thursday it has raised $27 million in a Series A funding round led by Prime Movers Lab. read more

Cansortium Investors Pull Back After Q4 Print: What Cannabis Stock Investors Need To Know

Vertically integrated cannabis company Cansortium Inc. (CSE: TIUM) (OTCQB: CNTMF), which operates under the Fluent brand, announced its fourth-quarter and full-year 2020 financial results Monday. read more

TechforCann, Europe's Cannabis Tech Accelerator, Raises $3 Million

Medical cannabis tech accelerator TechforCann Europe announced this week that it raised 2.5 million euros ($3 million) from Malta Enterprise, the island's governmental innovation agency. read more